Louisiana Funds — 2013 Investments
1 investments dated 2013 · listed companies and verified rows first · show all
NuPotentialnupotentialinc.comOct 2013
Developing 'Epi-drugs' that modulate epigenetic targets for cancer and other diseases.
BiotechBaton Rouge, US
Kenneth J Eilertsen(Director)
BoardJoan P Neuscheler(Executive Officer, Director)Ross Barrett(Director)Charles Oehler(Director)Joseph F Lovett(Executive Officer, Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.